Curevo Health
About the company
Curevo Health delivers specialist-led digital care that integrates seamlessly with primary care. We move patients from referral to treatment within days instead of months. Funded solely through the standard patient fee, our care is both sustainable and profitable, creating a model with no financial burden on clinics, regions, or public funds. Our system preserves GP continuity while AI automation handles everything from anamnesis to documentation, making high-quality specialist care up to 87 percent more cost-efficient.
The model is scalable, fully compatible with the existing healthcare system, and designed to relieve pressure on physical care. The result is shorter queues, lower system costs, and more time for human care. Currently we have signed well known angels with insights and contact networks in the market such as Claes Dinkelspiel (founder of Nordnet and Öhman group), Johan Färnstrand (former CEO of Aleris) and the chief psychiatrist Alexander Tsegaye .
Quick links:
Contact:
Dr. Dorél Lehrer, CEO, Co-founder
dorel@curevohealth.com
+46 73 81 752 73
Capital need and valuation:
Capital Need: €500,000
Pre-Money Valuation: Startup
Use of Funds
• Scale our B2B2C referral engine with partner clinics (low CAC, distribution-led growth).
• Expand dermatology and strengthen referral pathways; new verticals with same strategy for increased patient flow.
• Grow core team (sales, partnerships, product).
• Compliance, integrations and readiness for international launch (legal/regulatory, data protection).
Financial forecast
Estimated Turnover 2026/2027: €600,000.
Based on strategy plan with capital; recurring revenue model 389 SEK per visit, 6 (conservative) recurring visits yearly/patient and growing referral volumes from partner clinics.
Revenue Model: Verticals/diagnosis with a high recurring visit rate with pay-per-visit at €39 paid by the patient; €0 to clinics/regions (B2B2C via standard referrals as distribution).
Previous investments
Founders have invested: €20 000
External investors: SSE Business Lab convertible €30 000
Vision and impact
Replace waiting with care by creating affordable specialist teams one referral away, at zero cost for the care system.
• System impact: Shorter queues to specialists, lower system costs, reduced economic leakage from healthcare, and improved continuity/quality.
Total system cost:
87% cheaper total system cost compared to a normal physical visit, which we are freeing up for other patients further reducing waiting times.
30% cheaper than cheapest competitors which aggressively bill healthcare without constraints.
57% cheaper than most popular competitor for obesity but better, only licensed medical personel allowed.
- Patient impact: Faster access to obesity and dermatology specialist care at the standard patient fee. 4x cheaper care than largest competitor in the obesity field.
- SDG alignment: SDG 3 (Good Health & Well-Being), SDG 9 (Industry, Innovation & Infrastructure), SDG 10
(Reduced Inequalities).
Risk management
- Regulatory & Data: We use our own AI, servers and automations for admin only (for now); licensed clinicians make medical decisions but can utilize MDR registered tools like AI-models for cancer detection and increased efficiency. All chats, video calls, AI-models and health data resides in the EHR system.
IVO registration, GDPR compliance; data minimization and audit trails. PDL-compliant and NMI certified plattform.
- Market Adoption: Zero cost to clinics/regions and referral-based workflows lower friction; working patient flows with several partner clinics de-risk go-to-market.
- Operations & Staffing: Panel of licensed clinicians with flexible shifts; standardized pathways and QA; pool of at least 50 specialist doctors to balance demand peaks.
- Technology Dependence: Standards-based integrations with other EHR; robust logging and rollback plans.
AI-enabled workflows make us dependent on our tech stack. Crisis plans and functions are in place if servers go down.
- Policy Changes: Scenario planning for pricing and new units; diversified clinic mix. Different rules in different regions and countries, plan B and C if certain laws are changed which is expected in the near future accelerating our growth.